Drugs & TargetsFree Opdivo sBLA receives FDA acceptance and Priority Review for adjuvant treatment for patients with muscle-invasive urothelial carcinoma May 07, 2021Vol.47 No.18
Drugs & TargetsFree Xtandi approved by European Commission for men with metastatic hormone-sensitive prostate cancer May 07, 2021Vol.47 No.18
Drugs & TargetsFree Janssen submits Marketing Authorization Application to EMA seeking approval of cilta-cel for relapsed and/or refractory multiple myeloma May 07, 2021Vol.47 No.18
Conversation with The Cancer LetterFree We ask FDA to explain “dangling” accelerated approvals—and this week’s ODAC agenda April 30, 2021Vol.47 No.17By Paul Goldberg
FreeIn the Archives Roswell Park’s Eva Noles and NCI’s Carl Baker: “When I start something, I want to finish it” April 30, 2021Vol.47 No.17
Cancer History ProjectFreeGuest Editorial Chernobyl: a 35 year follow up on long-term health effects April 23, 2021Vol.47 No.16By Robert Peter Gale
FreeIn the Archives Vincent T. DeVita, Jr. on the National Cancer Act: “Money does buy ideas” April 23, 2021Vol.47 No.16
Film & TVFree A film documents deadly aftermath of power morcellation and the campaign to stop it April 16, 2021Vol.47 No.15By Paul Goldberg
FreeIn the Archives H. Lee Moffitt, and 11 years of NCCS Networker archives April 16, 2021Vol.47 No.15
Conversation with The Cancer LetterFree Karen Knudsen named CEO of the American Cancer Society April 12, 2021Vol.47 No.15By Paul Goldberg
